These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 391686)

  • 21. A cost-effectiveness analysis of aspirin versus oral anticoagulants after acute myocardial infarction in Italy -- equivalence of costs as a possible case for oral anticoagulants.
    Gianetti J; Gensini G; De Caterina R
    Thromb Haemost; 1998 Dec; 80(6):887-93. PubMed ID: 9869155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiplatelet therapy in coronary heart disease. Emerging strategies for the treatment and prevention of acute myocardial infarction.
    Becker RC
    Arch Pathol Lab Med; 1993 Jan; 117(1):89-96. PubMed ID: 8418769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Secondary prevention after myocardial infarction in the aged (author's transl)].
    Michel D
    Aktuelle Gerontol; 1982 Jul; 12(4):149-54. PubMed ID: 6126140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
    Sherry S
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782
    [No Abstract]   [Full Text] [Related]  

  • 25. [Angiotensin converting enzyme inhibitors during acute phase of myocardial infarct].
    Mazzotta G; Vecchio C
    G Ital Cardiol; 1994 Jan; 24(1):59-70. PubMed ID: 8200499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical impact of local implementation of agreed guidelines for the management of patients with acute myocardial infarction.
    Badano L; Cassin M; Solinas L; Burelli C; Macor F; Zanuttini D
    G Ital Cardiol; 1999 Jan; 29(1):39-47. PubMed ID: 9987046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical trials of platelet-active drugs in coronary heart disease: summary of design features.
    Furberg CD; May GS
    Circulation; 1980 Dec; 62(6 Pt 2):V49-52. PubMed ID: 7002352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Second prevention following myocardial infarct].
    Burkart F
    Schweiz Med Wochenschr; 1984 Jan; 114(3):104-7. PubMed ID: 6142527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled ex-vivo effect of sulfinpyrazone on platelet function of myocardial infarction patients.
    Cortellaro M; Fassio G; Boschetti C; Basagni M; Polli EE
    Haematologica; 1979 Apr; 64(2):173-89. PubMed ID: 112008
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
    Noll G; Kaufmann U; Wenzel RR; Lüscher TF
    Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind trial to assess long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Report of the Sixty Plus Reinfarction Study Research Group.
    Lancet; 1980 Nov; 2(8202):989-94. PubMed ID: 6107674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet function and response to aspirin: gender-specific features and implications for female thrombotic risk and management.
    Zuern CS; Lindemann S; Gawaz M
    Semin Thromb Hemost; 2009 Apr; 35(3):295-306. PubMed ID: 19452405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-term anticoagulant treatment following an acute myocardial infarction].
    van Bergen PF
    Ned Tijdschr Geneeskd; 1990 Oct; 134(41):1984-5. PubMed ID: 2234160
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prevention of cardiovascular complications in manifest arteriosclerosis by the use of Micristine].
    Heine H; Norden C; Heinemann L; Stepanauskas M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):804-9. PubMed ID: 94872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Do you still consider anticoagulant therapy for the prevention of coronary infarct a necessary indication today?].
    Med Welt; 1978 Nov; 29(45):1743-5. PubMed ID: 101731
    [No Abstract]   [Full Text] [Related]  

  • 37. A critique of methodology in studies of anticoagulant therapy for acute myocardial infarction.
    Gifford RH; Feinstein AR
    N Engl J Med; 1969 Feb; 280(7):351-7. PubMed ID: 4883585
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term anticoagulant prophylaxis after myocardial infarction.
    Seaman AJ; Griswold HE; Reaume RB; Ritzmann L
    N Engl J Med; 1969 Jul; 281(3):115-9. PubMed ID: 4307139
    [No Abstract]   [Full Text] [Related]  

  • 39. [Course control of platelet function and blood lipid levels during a 2 years prospective study on the prevention of reinfarction with acetylsalicylic acid, phenprocoumon and placebo].
    Walter E; Weber E; Loew D
    Verh Dtsch Ges Inn Med; 1978; (84):1481-5. PubMed ID: 369187
    [No Abstract]   [Full Text] [Related]  

  • 40. Secondary prevention trials after acute myocardial infarction.
    Furberg CD
    Am J Cardiol; 1987 Jul; 60(2):28A-32A. PubMed ID: 2887098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.